Stock News

Phillips 66 (PSX) Market Value Declined While Private Trust Co Has Upped Position by $361,681; Evercore Wealth Management Has Boosted Its Position in Aveo Pharmaceuticals (AVEO) by $500,000 as Stock Declined

Phillips 66 (NYSE:PSX) Logo

Private Trust Co increased its stake in Phillips 66 (PSX) by 61.84% based on its latest 2017Q4 regulatory filing with the SEC. Private Trust Co bought 3,581 shares as the company’s stock declined 5.13% with the market. The institutional investor held 9,372 shares of the integrated oil company at the end of 2017Q4, valued at $947,000, up from 5,791 at the end of the previous reported quarter. Private Trust Co who had been investing in Phillips 66 for a number of months, seems to be bullish on the $56.77B market cap company. The stock increased 3.14% or $3.71 during the last trading session, reaching $121.87. About 3.57 million shares traded or 51.86% up from the average. Phillips 66 (NYSE:PSX) has risen 23.90% since May 18, 2017 and is uptrending. It has outperformed by 12.35% the S&P500.

Evercore Wealth Management Llc increased its stake in Aveo Pharmaceuticals Inc (AVEO) by 148.44% based on its latest 2017Q4 regulatory filing with the SEC. Evercore Wealth Management Llc bought 250,000 shares as the company’s stock declined 2.67% with the market. The institutional investor held 418,414 shares of the health care company at the end of 2017Q4, valued at $1.17 million, up from 168,414 at the end of the previous reported quarter. Evercore Wealth Management Llc who had been investing in Aveo Pharmaceuticals Inc for a number of months, seems to be bullish on the $328.34 million market cap company. The stock decreased 2.29% or $0.05 during the last trading session, reaching $2.13. About 1.24M shares traded. AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) has risen 351.31% since May 18, 2017 and is uptrending. It has outperformed by 339.76% the S&P500.

Since December 15, 2017, it had 0 buys, and 1 sale for $270,675 activity.

More notable recent Phillips 66 (NYSE:PSX) news were published by: Investorplace.com which released: “5 Notable Dividend Increases From the Past Week — Including Phillips 66” on May 15, 2018, also Livetradingnews.com with their article: “Wall Street’s Top Analysts Upgrades, Downgrades & Initiations” published on May 18, 2018, Seekingalpha.com published: “Chasing The Elephant: Episode 8 Option Ideas” on May 16, 2018. More interesting news about Phillips 66 (NYSE:PSX) were released by: Investorplace.com and their article: “10 Small-Cap Oil & Gas Stocks to Watch” published on May 17, 2018 as well as Benzinga.com‘s news article titled: “Warren Buffett Pushing More Cash To Equities; ‘Big 5’ Stocks Still At The Top” with publication date: May 16, 2018.

Investors sentiment increased to 1.01 in 2017 Q4. Its up 0.09, from 0.92 in 2017Q3. It is positive, as 34 investors sold PSX shares while 372 reduced holdings. 125 funds opened positions while 284 raised stakes. 351.44 million shares or 0.51% less from 353.24 million shares in 2017Q3 were reported. Conning Incorporated holds 19,131 shares or 0.06% of its portfolio. Castleark Mgmt Limited owns 0.07% invested in Phillips 66 (NYSE:PSX) for 22,520 shares. First Trust Advsr Limited Partnership holds 0.04% or 155,853 shares in its portfolio. Signaturefd Llc reported 2,259 shares. Old Republic Corp invested 1.26% of its portfolio in Phillips 66 (NYSE:PSX). Karpas Strategies Ltd Co reported 7,896 shares. Hennessy Advisors invested 0.21% of its portfolio in Phillips 66 (NYSE:PSX). Cypress Asset Management Inc Tx holds 4,207 shares or 0.09% of its portfolio. Us Retail Bank De accumulated 0.11% or 358,360 shares. Allen Invest Mngmt Limited Liability invested in 3,325 shares. Lincoln Ltd Liability reported 4.62% in Phillips 66 (NYSE:PSX). Timber Hill Ltd Liability accumulated 32,365 shares. Old Mutual Customised Solutions (Proprietary) Ltd has 0.34% invested in Phillips 66 (NYSE:PSX). 634,415 were reported by Prudential. Hsbc Public Ltd Company has invested 0.17% in Phillips 66 (NYSE:PSX).

Among 20 analysts covering Phillips 66 (NYSE:PSX), 9 have Buy rating, 2 Sell and 9 Hold. Therefore 45% are positive. Phillips 66 had 81 analyst reports since August 4, 2015 according to SRatingsIntel. Cowen & Co maintained Phillips 66 (NYSE:PSX) rating on Monday, September 11. Cowen & Co has “Buy” rating and $95.0 target. The stock of Phillips 66 (NYSE:PSX) has “Neutral” rating given on Monday, August 22 by Piper Jaffray. RBC Capital Markets maintained Phillips 66 (NYSE:PSX) on Wednesday, December 20 with “Hold” rating. Jefferies maintained it with “Sell” rating and $79.0 target in Wednesday, December 20 report. The firm earned “Buy” rating on Thursday, September 28 by Scotia Capital. Cowen & Co maintained the stock with “Buy” rating in Friday, July 7 report. The firm has “Sector Perform” rating given on Monday, July 11 by Howard Weil. The firm earned “Neutral” rating on Wednesday, January 24 by Citigroup. The firm has “Outperform” rating by Credit Suisse given on Tuesday, January 26. Jefferies initiated the stock with “Hold” rating in Tuesday, August 23 report.

Private Trust Co, which manages about $472.56M US Long portfolio, decreased its stake in 3M Company (NYSE:MMM) by 1,579 shares to 19,591 shares, valued at $4.61M in 2017Q4, according to the filing. It also reduced its holding in At&T Inc. (NYSE:T) by 14,144 shares in the quarter, leaving it with 120,441 shares, and cut its stake in First Republic Bank San Fran (NYSE:FRC).

Evercore Wealth Management Llc, which manages about $4.87 billion and $2.69B US Long portfolio, decreased its stake in Ishares Tr (IWD) by 14,550 shares to 160,574 shares, valued at $19.97 million in 2017Q4, according to the filing. It also reduced its holding in Allergan Plc by 51,511 shares in the quarter, leaving it with 65,151 shares, and cut its stake in Oracle Corp (NYSE:ORCL).

Investors sentiment increased to 2.81 in 2017 Q4. Its up 1.49, from 1.32 in 2017Q3. It is positive, as 4 investors sold AVEO shares while 12 reduced holdings. 26 funds opened positions while 19 raised stakes. 59.55 million shares or 0.59% less from 59.90 million shares in 2017Q3 were reported. Venbio Select Advisor Lc stated it has 0.72% in AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO). Acuta Capital Prns Lc invested in 0.07% or 124,338 shares. Massachusetts-based Geode Cap Limited Liability Co has invested 0% in AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO). Spark Management Ltd Co holds 0.04% of its portfolio in AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) for 268,200 shares. Raymond James Financial invested in 11,350 shares or 0% of the stock. Tower Rech Capital Ltd (Trc) holds 34,378 shares. Asset Mngmt owns 100,010 shares or 0.04% of their US portfolio. Bancorp Of America De holds 6,000 shares or 0% of its portfolio. Pnc Services has invested 0% of its portfolio in AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO). 300,000 are owned by Point72 Asset Management Lp. Armistice Capital Ltd Llc holds 0.17% or 600,000 shares. Credit Suisse Ag stated it has 0% of its portfolio in AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO). Morgan Stanley owns 138,926 shares for 0% of their portfolio. Grimes & Inc invested in 0.01% or 22,600 shares. Citigroup holds 0% or 2,679 shares.

Since April 6, 2018, it had 20 insider buys, and 0 selling transactions for $22.66 million activity. BARRIS PETER J bought $2.12M worth of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) on Friday, April 6. $2.12M worth of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) was bought by Florence Anthony A. Jr.. The insider MOTT DAVID M bought 920,976 shares worth $2.12M. SANDELL SCOTT D bought $2.12M worth of stock. Growth Equity Opportunities IV – LLC bought $2.12M worth of stock or 920,976 shares. 70,873 AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) shares with value of $151,250 were bought by BASKETT FOREST.

More recent AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) news were published by: Seekingalpha.com which released: “3 Things In Biotech, May 9: New AML Therapy Imminent? AVEO Hedges, Rockwell Boosts Iron” on May 10, 2018. Also Nasdaq.com published the news titled: “Factors of Influence in 2018, Key Indicators and Opportunity within FNB, Comcast, IZEA, AVEO Pharmaceuticals …” on May 09, 2018. Fool.com‘s news article titled: “Here’s Why AVEO Pharmaceuticals Fell as Much as 17% Today” with publication date: May 08, 2018 was also an interesting one.

Among 3 analysts covering AVEO Pharmaceuticals (NASDAQ:AVEO), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. AVEO Pharmaceuticals had 15 analyst reports since March 30, 2016 according to SRatingsIntel. Piper Jaffray maintained AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) rating on Thursday, October 5. Piper Jaffray has “Buy” rating and $5.0 target. The firm has “Overweight” rating given on Thursday, May 19 by Piper Jaffray. The firm earned “Buy” rating on Thursday, March 29 by Piper Jaffray. Piper Jaffray maintained it with “Buy” rating and $3.5000 target in Wednesday, August 9 report. The stock has “Buy” rating by FBR Capital on Thursday, March 22. The stock of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) has “Buy” rating given on Tuesday, March 13 by FBR Capital. FBR Capital maintained it with “Buy” rating and $5.0 target in Tuesday, January 16 report. The firm has “Buy” rating given on Monday, February 12 by FBR Capital. The firm has “Buy” rating given on Thursday, December 7 by FBR Capital. The rating was maintained by FBR Capital with “Buy” on Monday, June 26.

Phillips 66 (NYSE:PSX) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *